Skip to main content

TransMedics Group, Inc.

TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001756262

In the last 90 days, TransMedics Group, Inc. insiders filed 1 open-market purchase and 0 sales; 375 institutions reported holding it in 13F filings for Q2 2026, worth $2.31B in total; no superinvestor holds it.

Holders of 5% or more of TMDX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of TransMedics Group, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of TMDX
HolderLatest formStakeChangeFirst filedLatest filingFiling
FMR LLC13G/A15.00%5.06M shares+2.10 ppfrom 12.90%Dec 6, 20242 filingsMay 12, 2025SEC
BlackRock, Inc.13G/A14.60%4.96M shares–Jul 18, 20251 filingJul 18, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on TransMedics Group, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TMDX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 27, 20261:34 PM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Jul 18, 202511:46 AM ETBlackRock, Inc.13G/A14.60%4.96M shares–Jun 30, 2025SEC
May 12, 202510:43 AM ETFMR LLCand 1 other13G/A15.00%5.06M shares+2.10 ppfrom 12.90%Mar 31, 2025SEC
Dec 6, 202411:38 AM ETFMR LLCand 1 other13G/A12.90%4.36M shares–Nov 29, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell TransMedics Group, Inc. shares.

No Form 144 notices for TransMedics Group, Inc. are on file.